Cargando…
Gene Therapy for Hemophilia A: A Mixed Methods Study of Patient Preferences and Shared Decision-Making
PURPOSE: As gene therapies for hemophilia are incorporated into clinical practice, shared decision-making (SDM) is recommended for implementation. SDM tools may facilitate informed decision-making for gene therapy and other novel therapies. OBJECTIVE: To inform the development of SDM tools for hemop...
Autores principales: | Limjoco, Jacqueline, Thornburg, Courtney D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123005/ https://www.ncbi.nlm.nih.gov/pubmed/37102127 http://dx.doi.org/10.2147/PPA.S406894 |
Ejemplares similares
-
The odds and implications of coinheritance of hemophilia A and B
por: Karch, Corinne, et al.
Publicado: (2020) -
Etranacogene dezaparvovec for hemophilia B gene
therapy
por: Thornburg, Courtney D.
Publicado: (2021) -
The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making
por: Wang, Michael, et al.
Publicado: (2022) -
Evaluating Gene Therapy as a Potential Paradigm Shift in Treating Severe Hemophilia
por: Thornburg, Courtney D., et al.
Publicado: (2023) -
Treatment adherence in hemophilia
por: Thornburg, Courtney D, et al.
Publicado: (2017)